These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11525567)

  • 21. The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.
    Lin B; Podar K; Gupta D; Tai YT; Li S; Weller E; Hideshima T; Lentzsch S; Davies F; Li C; Weisberg E; Schlossman RL; Richardson PG; Griffin JD; Wood J; Munshi NC; Anderson KC
    Cancer Res; 2002 Sep; 62(17):5019-26. PubMed ID: 12208756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
    Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
    Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of neutralizing monoclonal antibody against human vascular endothelial growth factor receptor II.
    Li R; Xiong DS; Shao XF; Liu J; Xu YF; Xu YS; Liu HZ; Zhu ZP; Yang CZ
    Acta Pharmacol Sin; 2004 Oct; 25(10):1292-8. PubMed ID: 15456530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family.
    Dalal S; Berry AM; Cullinane CJ; Mangham DC; Grimer R; Lewis IJ; Johnston C; Laurence V; Burchill SA
    Clin Cancer Res; 2005 Mar; 11(6):2364-78. PubMed ID: 15788688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
    Mazitschek R; Giannis A
    Curr Opin Chem Biol; 2004 Aug; 8(4):432-41. PubMed ID: 15288254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cloning and monoclonal antibody preparation of VEGF receptor KDR extracellular V-VII domain and KDR expression in carcinomas of different origins].
    Song S; Zeng L; Wu J
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):96-8. PubMed ID: 11776867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy.
    Hansen-Algenstaedt N; Stoll BR; Padera TP; Dolmans DE; Hicklin DJ; Fukumura D; Jain RK
    Cancer Res; 2000 Aug; 60(16):4556-60. PubMed ID: 10969807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opinion DGVS the IQWiG report for early benefit assessment of aflibercept for the treatment of metastatic colorectal cancer according to ยง 35a SGB V on May 29, 2013].
    Z Gastroenterol; 2013 Aug; 51(8):1019-22. PubMed ID: 24298632
    [No Abstract]   [Full Text] [Related]  

  • 32. Hunting and trapping the vascular endothelial growth factor.
    Dowlati A
    J Clin Oncol; 2010 Jan; 28(2):185-7. PubMed ID: 19949005
    [No Abstract]   [Full Text] [Related]  

  • 33. New targets and non-cytotoxics in ovarian cancer.
    Eisenhauer EA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x247-50. PubMed ID: 17018733
    [No Abstract]   [Full Text] [Related]  

  • 34. "HIT"ing back against NETs.
    Swaidani S; McCrae KR
    Blood; 2020 Mar; 135(10):706-707. PubMed ID: 32135015
    [No Abstract]   [Full Text] [Related]  

  • 35. Testing cancer inhibitors at scale.
    Saraon P; Grozavu I; Stagljar I
    Nat Biomed Eng; 2018 Apr; 2(4):203-204. PubMed ID: 30936440
    [No Abstract]   [Full Text] [Related]  

  • 36. Ramucirumab (IMC-1121B): Monoclonal antibody inhibition of vascular endothelial growth factor receptor-2.
    Spratlin J
    Curr Oncol Rep; 2011 Apr; 13(2):97-102. PubMed ID: 21222245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic Effect of Immunotoxin Containing The Truncated Form of Pseudomonas Exotoxin A and Anti-VEGFR2 on HUVEC and MCF-7 Cell Lines.
    Safari E; Zavaran Hosseini A; Hassan Z; Khajeh K; Ardestani MS; Baradaran B
    Cell J; 2014; 16(2):203-10. PubMed ID: 24567937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
    Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
    MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted molecular therapy of GBM.
    Mischel PS; Cloughesy TF
    Brain Pathol; 2003 Jan; 13(1):52-61. PubMed ID: 12580545
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.